When groups advocating for patients are paid for by Big Pharma
If patients have more choice, that can only be a good thing, right?
In this talk, Sharon Batt, author of Health Advocacy, Inc., explains how such seemingly positive ideas are used by pharmaceutical companies to help sell ineffective drugs. If patients can ask for any treatment, it means companies can sell drugs they know do not work or that have little scientific support. The guise of freedom can facilitate snake oil.
Groups that represent patients are sometimes loud proponents of such messages. Sharon Batt’s research has exposed that many of these groups are in fact funded by pharmaceutical companies. In promoting causes that sound beneficial for patients, they echo the marketing and lobbying messages of drug companies. Seemingly innocuous goals, such as a Patient’s Bill of Rights, can be used as a tool to push governments to pay for any medications without regard to their price or efficacy.
Her talk was given at the Mario Negri Institute, Milan, on October 24, 2018. Sharon Batt is a professor and researcher at Dalhousie University, Halifax, Nova Scotia, Canada. She is the author of Health Advocacy, Inc.: How Pharmaceutical Funding Changed the Breast Cancer Movement.